Literature DB >> 35979209

Influence of Co-morbidities During SARS-CoV-2 Infection in an Indian Population.

Adrian Matysek1,2, Aneta Studnicka3, Wade Menpes Smith1,2, Michał Hutny4, Paweł Gajewski5, Krzysztof J Filipiak6, Jorming Goh7,8,9, Guang Yang10,11.   

Abstract

Background: Since the outbreak of COVID-19 pandemic the interindividual variability in the course of the disease has been reported, indicating a wide range of factors influencing it. Factors which were the most often associated with increased COVID-19 severity include higher age, obesity and diabetes. The influence of cytokine storm is complex, reflecting the complexity of the immunological processes triggered by SARS-CoV-2 infection. A modern challenge such as a worldwide pandemic requires modern solutions, which in this case is harnessing the machine learning for the purpose of analysing the differences in the clinical properties of the populations affected by the disease, followed by grading its significance, consequently leading to creation of tool applicable for assessing the individual risk of SARS-CoV-2 infection.
Methods: Biochemical and morphological parameters values of 5,000 patients (Curisin Healthcare (India) were gathered and used for calculation of eGFR, SII index and N/L ratio. Spearman's rank correlation coefficient formula was used for assessment of correlations between each of the features in the population and the presence of the SARS-CoV-2 infection. Feature importance was evaluated by fitting a Random Forest machine learning model to the data and examining their predictive value. Its accuracy was measured as the F1 Score.
Results: The parameters which showed the highest correlation coefficient were age, random serum glucose, serum urea, gender and serum cholesterol, whereas the highest inverse correlation coefficient was assessed for alanine transaminase, red blood cells count and serum creatinine. The accuracy of created model for differentiating positive from negative SARS-CoV-2 cases was 97%. Features of highest importance were age, alanine transaminase, random serum glucose and red blood cells count.
Conclusion: The current analysis indicates a number of parameters available for a routine screening in clinical setting. It also presents a tool created on the basis of these parameters, useful for assessing the individual risk of developing COVID-19 in patients. The limitation of the study is the demographic specificity of the studied population, which might restrict its general applicability.
Copyright © 2022 Matysek, Studnicka, Smith, Hutny, Gajewski, Filipiak, Goh and Yang.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; blood biomarkers; machine learning; vitamin D

Year:  2022        PMID: 35979209      PMCID: PMC9377050          DOI: 10.3389/fmed.2022.962101

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  69 in total

1.  Does vitamin D deficiency increase the severity of COVID-19?

Authors:  E Kenneth Weir; Thenappan Thenappan; Maneesh Bhargava; Yingjie Chen
Journal:  Clin Med (Lond)       Date:  2020-06-05       Impact factor: 2.659

2.  Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection.

Authors:  José L Hernández; Daniel Nan; Marta Fernandez-Ayala; Mayte García-Unzueta; Miguel A Hernández-Hernández; Marcos López-Hoyos; Pedro Muñoz-Cacho; José M Olmos; Manuel Gutiérrez-Cuadra; Juan J Ruiz-Cubillán; Javier Crespo; Víctor M Martínez-Taboada
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

3.  Serum biomarkers for prediction of mortality in patients with COVID-19.

Authors:  Rohit S Loomba; Enrique G Villarreal; Juan S Farias; Gaurav Aggarwal; Saurabh Aggarwal; Saul Flores
Journal:  Ann Clin Biochem       Date:  2021-05-14       Impact factor: 2.057

Review 4.  COVID-19: Transmission, prevention, and potential therapeutic opportunities.

Authors:  Melika Lotfi; Michael R Hamblin; Nima Rezaei
Journal:  Clin Chim Acta       Date:  2020-05-29       Impact factor: 3.786

Review 5.  Sex-based differences in severity and mortality in COVID-19.

Authors:  Mustafa Alwani; Aksam Yassin; Raed M Al-Zoubi; Omar M Aboumarzouk; Joanne Nettleship; Daniel Kelly; Ahmad R Al-Qudimat; Ridwan Shabsigh
Journal:  Rev Med Virol       Date:  2021-03-01       Impact factor: 11.043

Review 6.  Immunity, atherosclerosis and cardiovascular disease.

Authors:  Johan Frostegård
Journal:  BMC Med       Date:  2013-05-01       Impact factor: 8.775

7.  Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.

Authors:  Gian Paolo Fadini; Mario Luca Morieri; Federico Boscari; Paola Fioretto; Alberto Maran; Luca Busetto; Benedetta Maria Bonora; Elisa Selmin; Gaetano Arcidiacono; Silvia Pinelli; Filippo Farnia; Daniele Falaguasta; Lucia Russo; Giacomo Voltan; Sara Mazzocut; Giorgia Costantini; Francesca Ghirardini; Silvia Tresso; Anna Maria Cattelan; Andrea Vianello; Angelo Avogaro; Roberto Vettor
Journal:  Diabetes Res Clin Pract       Date:  2020-08-15       Impact factor: 5.602

8.  Modeling and prediction of the 2019 coronavirus disease spreading in China incorporating human migration data.

Authors:  Choujun Zhan; Chi K Tse; Yuxia Fu; Zhikang Lai; Haijun Zhang
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

9.  Elevated glucose level leads to rapid COVID-19 progression and high fatality.

Authors:  Wenjun Wang; Mingwang Shen; Yusha Tao; Christopher K Fairley; Qin Zhong; Zongren Li; Hui Chen; Jason J Ong; Dawei Zhang; Kai Zhang; Ning Xing; Huayuan Guo; Enqiang Qin; Xizhou Guan; Feifei Yang; Sibing Zhang; Lei Zhang; Kunlun He
Journal:  BMC Pulm Med       Date:  2021-02-24       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.